Asaf Danziger

2021

In 2021, Asaf Danziger earned a total compensation of $1.2M as Chief Executive Officer at NovoCure, a 87% decrease compared to previous year.

Compensation breakdown

Salary$876,086
Other$303,197
Total$1,179,283

Danziger received $876.1K in salary, accounting for 74% of the total pay in 2021.

Danziger also received $303.2K in other compensation.

Rankings

In 2021, Asaf Danziger's compensation ranked 8,186th out of 12,415 executives tracked by ExecPay. In other words, Danziger earned more than 34.1% of executives.

ClassificationRankingPercentile
All
8,186
out of 12,415
34th
Division
Manufacturing
3,621
out of 5,508
34th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
464
out of 801
42nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
291
out of 522
44th
Industry
Surgical and Medical Instruments and Apparatus
187
out of 327
43rd
Source: SEC filing on April 25, 2022.

Danziger's colleagues

We found four more compensation records of executives who worked with Asaf Danziger at NovoCure in 2021.

2021

Wilhelmus Groenhuysen

NovoCure

Chief Operating Officer

2021

Pritesh Shah

NovoCure

Chief Commercial Officer

2021

Ashley Cordova

NovoCure

Chief Financial Officer

2021

Todd Longsworth

NovoCure

General Counsel

News

You may also like